Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01418495 · ClinicalTrials.gov registry record
Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 12
- Enrollment target
NCT01418495: Completed study, sponsored by National Cancer Institute (NCI).
NCT01418495 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01418495 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
This research trial is studying how Ch14.18 acts in the body of younger patients with high-risk neuroblastoma. Studying samples of blood from patients with cancer receiving Ch14.18 may help doctors learn more about how this drug is used by the body to develop better ways to give the drug to potentially improve its effectiveness and lessen its side effects.
Interventions
- OTHER Cytology Specimen Collection Procedure
- OTHER Pharmacological Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2011-05-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01418495
The ClinicalTrials.gov registry entry for NCT01418495 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Cytology Specimen Collection Procedure is the first listed.
NCT01418495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01418495 about?
NCT01418495 is a clinical study titled "Pharmacokinetics of Ch14.18 in Younger Patients With High-Risk Neuroblastoma". This research trial is studying how Ch14.18 acts in the body of younger patients with high-risk neuroblastoma. Studying samples of blood from patients with cancer receiving Ch14.18 may help doctors learn more about how this drug is used by the body to develop better ways to give the drug to potentia...
What is the current status of trial NCT01418495?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2011-05-26.
What interventions are being tested in trial NCT01418495?
The interventions under investigation include: Cytology Specimen Collection Procedure (OTHER), Pharmacological Study (OTHER).
Who is sponsoring clinical trial NCT01418495?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.